Life Sciences Company Seer To Launch Unparalleled Proteomics Platform

Seer posits that its innovative technology will be a game-changer for medical researchers, doctors, as well as patients. While most early detection relies on the genetic likelihood of diseases, Seer hopes to detect the signature of diseases due to changes in an individual’s proteome...